Literature DB >> 18959819

Proteomic analysis of androgen-independent growth in low and high passage human LNCaP prostatic adenocarcinoma cells.

Yun Hee Youm1, Seyoon Kim, Young Yil Bahk, Tag Keun Yoo.   

Abstract

The present study compared the proteomic characteristics of a low passage number (L-33) and high passage number (H-81) LNCaP cell clone. Marked differences in protein expression were noted in the response of L-33 and H-81 cells to androgens. To investigate if regulation of these proteins was androgen-dependent, expression of the androgen receptor was silenced via small interfering RNA. Consistent with the proteomic data, abrogation of androgen receptor production in H-81 cells resulted in the reversed expression level into L-33 cells compared with non-treated H-81 LNCaP cells. The results clarify the progression into an androgen-independent phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18959819     DOI: 10.5483/bmbrep.2008.41.10.722

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  6 in total

1.  Sensitivity of staurosporine-induced differentiated RGC-5 cells to homocysteine.

Authors:  Preethi S Ganapathy; Ying Dun; Yonju Ha; Jennifer Duplantier; John Bradley Allen; Amina Farooq; B Renee Bozard; Sylvia B Smith
Journal:  Curr Eye Res       Date:  2010-01       Impact factor: 2.424

2.  Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells.

Authors:  Harryl D Martinez; Jordy J Hsiao; Rohini J Jasavala; Izumi V Hinkson; Jimmy K Eng; Michael E Wright
Journal:  Genes Cancer       Date:  2011-10

3.  Molecular mechanism of prostate cancer cell apoptosis induced by busulfan via adjustment of androgen receptor phosphatization.

Authors:  Jun Liu; Guojun Jiang; Aiping Yang; Guohui Yang; Wenjuan Yang; Yi Fang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

4.  New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.

Authors:  Kuo-Pao Lai; Chiung-Kuei Huang; Yu-Jia Chang; Chin-Ying Chung; Shinichi Yamashita; Lei Li; Soo Ok Lee; Shuyuan Yeh; Chawnshang Chang
Journal:  Am J Pathol       Date:  2012-12-04       Impact factor: 4.307

5.  Expression of heat shock protein 27 in prostate cancer cell lines according to the extent of malignancy and doxazosin treatment.

Authors:  Seung Wook Lee; Jeong Woo Lee; Jae Hoon Chung; Jung Ki Jo
Journal:  World J Mens Health       Date:  2013-12-24       Impact factor: 5.400

6.  Inhibition of androgen receptor expression with small interfering RNA enhances cancer cell apoptosis by suppressing survival factors in androgen insensitive, late stage LNCaP cells.

Authors:  Sang Soo Kim; Hee Joo Cho; Jung Yoon Kang; Hee Kyu Kang; Tag Keun Yoo
Journal:  ScientificWorldJournal       Date:  2013-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.